Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture
Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture
复制标题
与脾破裂相关的自身免疫性淋巴增殖综合征患者的成功动脉栓塞
DOI:
10.1007/s10875-020-00809-3
复制
发表时间:
2020
影响因子:
9.1
通讯作者:
Kensaku Kohrogi et al.
中科院分区:
文献类型:
--
作者:
Kato Yu;Kunimasa Kazuhiro;Takahashi Mizuki;Harada Ayaka;Nagasawa Ikuko;Osawa Masanori;Sugimoto Yoshikazu;Tomida Akihiro;Go J. Yoshida;村上翔子;Kensaku Kohrogi et al.
To the Editor, Autoimmune lymphoproliferative syndrome (ALPS) is an autosomal dominant disorder of lymphocyte homeostasis wherein patients present with splenomegaly and lymphadenopathy [1]. ALPS results from defective apoptosis of T lymphocytes and accumulation of the T cell receptor α/β chainpositive and CD4 and CD8-negative double negative T (α/β-DNT) cells. This leads to lymphadenopathy and splenomegaly during the early years of life. Patients with ALPS exhibit elevated levels of α/β-DNT cells in the peripheral blood and lymphoid tissues [1]. Therapy for ALPS comprises steroids and immunosuppressants to improve immune cytopenia. Sirolimus was shown to be effective in autoimmune cytopenia in a recent prospective multi-institutional trial [2]. Splenomegaly is one of the complications of ALPS, and patients with remarkable splenomegaly are forced to limit their daily activities to prevent splenic rupture. Splenectomy should be avoided in ALPS patients owing to its limited efficiency for immune cytopenia and associated high risk of severe infection [3]. However, there are no treatment guidelines for managing splenic rupture in ALPS patients. Pediatric splenic rupture is a life-threatening organ injury that requires immediate intervention in certain cases. Although the main cause of splenic rupture is strong blunt trauma, idiopathic splenic rupture or splenic rupture following minor trauma has been reported in patients with splenomegaly [4]. In such cases, understanding the underlying cause (s) is imperative to design an appropriate treatment plan. However, the exact cause of splenomegaly cannot always be determined.
登录
查看更多内容
影响因子:
20.3
作者:
Bride, Karen L.;Vincent, Tiffaney;Teachey, David T.
通讯作者:
Teachey, David T.
DOI:
--
发表时间:
1997
期刊:
影响因子:
--
作者:
D. Livingston;R. Lavery;M. Passannante;T. Fabian;D. Fry;Malangoni
通讯作者:
Malangoni
影响因子:
20.3
作者:
S. Mineishi;J. Magenau;H. Tobai;A. Pawarode;E. Peres;P. Reddy;C. Kitko;S. Choi;H. Erba;Lisa A Kujawski;G. Yanik;J. Ferrara;J. Levine
通讯作者:
J. Levine
影响因子:
20.3
作者:
Neven, Benedicte;Magerus-Chatinet, Aude;Rieux-Laucat, Frederic
通讯作者:
Rieux-Laucat, Frederic
DOI:
10.1016/j.jvir.2019.05.031
发表时间:
2020
期刊:
Journal of vascular and interventional radiology : JVIR
影响因子:
--
作者:
B. Kis;M. Mills;Johnna Smith;Junsung Choi;Elizabeth M. Sagatys;R. Komrokji;J. Strosberg;R. Kim
通讯作者:
R. Kim